WANBURYWanbury Ltd.

₹249.95-1.50%

Market Cap

₹884.48 Cr

Stock P/E

20.58

ROCE

35.97%

ROE

84.21%

Book Value

₹25.52

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Public

Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Wanbury Ltd. exhibits strong revenue growth but struggles with profitability metrics due to a high debt equity ratio. In comparison to its peers, several companies outperform in profitability and valuation, with some showing signs of financial risk.

Key Points

• Wanbury Ltd. shows significant YoY revenue growth at 15.21%.
• Highest EPS growth is with Divi's Laboratories Ltd. at 82.53.
• Dr. Reddy's Laboratories Ltd. leads in ROE at 21.76%.
• Cipla Ltd. is the most attractively valued based on PE and PBV ratios.
• Mankind Pharma Ltd. shows exceptional growth trajectory with 155.25% 3-year revenue growth.

Top Performers

Mankind Pharma Ltd.

Highest 3-year revenue growth at 155.25% and strong profitability metrics.

Dr. Reddy's Laboratories Ltd.

Leads in profitability with a ROE of 21.76% and a low PE ratio of 15.50.

Cipla Ltd.

Best valuation metrics with a PE of 23.73 and strong profitability.